Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
400 participants
INTERVENTIONAL
2025-10-06
2030-06-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
How practical it is to offer another round of proven therapy. How effective different therapy options are for people who didn't respond to the first treatment.
The goal is to improve personalized care by:
Identifying factors that might predict how someone will respond to a second treatment.
Creating a simple tool to spot people who might not respond to treatment early, so they can start a different option sooner.
The findings will help improve PTSD care by offering better follow-up treatments and matching patients with the approach that works best for them.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Feasibility of Group-Based Metacognitive Therapy for PTSD
NCT07302334
Facilitating Transition to Recommended PTSD Treatment
NCT05165940
Exposure Therapy For Veterans With PTSD And Panic Attacks
NCT01033136
Examining Changes in Microbiota Over the Course of PTSD Treatment
NCT04109196
Reducing Dropout and Improving Outcomes From PTSD Therapy: When to Switch Therapies or Stay the Course
NCT06957067
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
SEQUENTIAL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Initial Course of Cognitive Processing Therapy
All participants will start in Arm 1 where they receive 10-sessions of Cognitive Processing Therapy.
Cognitive Processing Therapy
Cognitive Processing Therapy is a first-line intervention for the treatment of PTSD that focuses on changing unhelpful patterns of thinking.
Subsequent Treatment
At one-week follow up after initial Cognitive Processing Therapy, participants whose scores are 28 or above on the PTSD Checklist for DSM-5 will be offered a subsequent course of treatment.
Cognitive Processing Therapy
Cognitive Processing Therapy is a first-line intervention for the treatment of PTSD that focuses on changing unhelpful patterns of thinking.
Prolonged Exposure
Prolonged Exposure is an evidence-based treatment for PTSD that helps to reduce the intensity of distress by gradually exposing participants to trauma-related memories, feelings, and situations in real life.
Skills Training for Affective and Interpersonal Regulation
Skills Training for Affective and Interpersonal Regulation (STAIR) is a evidence-based treatment geared towards helping regulate emotional and interpersonal needs of those with PTSD.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Cognitive Processing Therapy
Cognitive Processing Therapy is a first-line intervention for the treatment of PTSD that focuses on changing unhelpful patterns of thinking.
Prolonged Exposure
Prolonged Exposure is an evidence-based treatment for PTSD that helps to reduce the intensity of distress by gradually exposing participants to trauma-related memories, feelings, and situations in real life.
Skills Training for Affective and Interpersonal Regulation
Skills Training for Affective and Interpersonal Regulation (STAIR) is a evidence-based treatment geared towards helping regulate emotional and interpersonal needs of those with PTSD.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Are fluent in English
* Have experienced a Criterion A traumatic event during their lifetime
* Have a PTSD diagnosis verified via the Clinician Administered PTSD Scale for DSM-5
* Are interested in receiving evidence-based treatment for PTSD and able to attend 10 therapy sessions over the course of 2 weeks (10 days) and could possibly attend another 10 sessions of a subsequent treatment (additional CPT sessions, PE, or STAIR)
* Are willing and able to complete self-report measures and clinician-rated assessments at multiple timepoints over the course of the study
Exclusion Criteria
* They are currently suicidal or homicidal (i.e., current plan and imminent intent)
* They have unmanaged psychosis or mania
* They have not been on a stable dose of psychotropic medication for at least one month at the time of the baseline assessment
* They have completed an evidence-based cognitive behavioral PTSD treatment in the past three months or are currently engaged in an evidence-based PTSD treatment (CPT, PE)
* They have an intellectual disability or significant cognitive impairment that would prevent them from engaging in treatment
* They have a serious or unstable medical illness or instability for which hospitalization may be likely within the next year
* They have an active substance use disorder (within the past three months) that would require immediate medical observation if substance was abruptly discontinued
* They are involved with current legal actions related to their index trauma
* They have a visual or auditory impairment that would prevent them from fully participating in study activities
* They, at the time of consent, appear to have extenuating life circumstances (i.e., unstable housing, no internet access, etc.) which, in the judgement of the study team, could affect the ability to deliver interventions with fidelity
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Rush University Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Philip Held
Research Director
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Rush University Medical Center
Chicago, Illinois, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
23091403
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.